Insights

Case Study: Learning About Real-World Coughers Through a Smartphone App

A decentralized feasibility study that delivered rich, real-world cough data without the scale, cost, or complexity of a trial or a market-research program.

Why the Most Effective Chronic Cough Treatment Is Also the Least Known

About 50% of patients with refractory chronic cough go into full remission; they don’t have a chronic cough anymore. Over 80% experience a significant reduction in their symptoms.

Refractory Chronic Cough (RCC) Therapy May Be One of the Most Asymmetric Bets in Respiratory

CHEST 2025: Improving Access to Chronic Cough Treatment Through a Digital Therapeutic Solution (Pharmacy Times)

Q&A: The New Standard for Measuring Cough with Tamsin Chislett

Digital Therapeutics Global Market Map (2025)

Q&A: The Future of Cough Care – Inside the First-Ever Cough DTx

Q&A with Dr. Nadia Giannetti

Q&A with Actigraph Christine Guo, Chief Scientific Officer

Continuous cough monitoring in oncology: a new promising frontier for early detection and improved outcomes

Hyfe's 8th Cough Science Forum

Overview of Regulatory Status for Current Cough Counting Devices on the Market

Q&A with Dr. Emily Henkle

Hyfe's 7th Cough Science Forum

Q&A with Dr. Grandjean Lapierre

Q&A with Alex Zimmer, McGill University

Q&A with Dr. Jane Reynolds, University of Montana

Q&A with Dr. Marc Judson

Acoustic AI Frameworks: Single-Sound Analysis vs. Continuous Cough Monitoring

Q&A with Dr Dominic Sykes - The first clinical trial integrating continuous longitudinal cough data with esophageal manometry